Get started
INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT)INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT)INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT)

INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT)

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0A43 chart


Full chart

0A43 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪66.42 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.48 USD
Net income (FY)
‪−135.12 M‬ USD
Revenue (FY)
‪832.01 K‬ USD
Shares float
‪35.69 M‬
Beta (1Y)
2.17

Employees


Employees (FY)
122
Change (1Y)
−62 −33.70%
Revenue / Employee (1Y)
‪6.82 K‬ USD
Net income / Employee (1Y)
‪−1.11 M‬ USD

About Inovio Pharmaceuticals, Inc.


Sector
Health Technology
CEO
Jacqueline E. Shea
Headquarters
Plymouth Meeting
Website
inovio.com
Founded
1983
FIGI
BBG00X93ZY44
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0A43 news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0A43 is 1.80 USD — it has decreased by −3.33% in the past 24 hours. Watch INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) stocks are traded under the ticker 0A43.
0A43 stock has fallen by −35.76% compared to the previous week, the month change is a −54.58% fall, over the last year INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) has showed a −60.77% decrease.
We've gathered analysts' opinions on INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) future price: according to them, 0A43 price has a max estimate of 18.00 USD and a min estimate of 5.00 USD. Watch 0A43 chart and read a more detailed INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) stock forecast: see what analysts think of INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) and suggest that you do with its stocks.
0A43 reached its all-time high on Feb 2, 2021 with the price of 234.84 USD, and its all-time low was 2.15 USD and was reached on Dec 13, 2024. View more price dynamics on 0A43 chart.
See other stocks reaching their highest and lowest prices.
0A43 stock is 6.02% volatile and has beta coefficient of 2.17. Track INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) stock price on the chart and check out the list of the most volatile stocks — is INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) there?
Today INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) has the market capitalization of ‪66.42 M‬, it has decreased by −26.12% over the last week.
Yes, you can track INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) financials in yearly and quarterly reports right on TradingView.
INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
0A43 earnings for the last quarter are −0.89 USD per share, whereas the estimation was −1.15 USD resulting in a 22.61% surprise. The estimated earnings for the next quarter are −0.92 USD per share. See more details about INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) earnings.
INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of ‪112.83 K‬ USD. In the next quarter, revenue is expected to reach ‪54.17 K‬ USD.
0A43 net income for the last quarter is ‪−25.17 M‬ USD, while the quarter before that showed ‪−32.24 M‬ USD of net income which accounts for 21.94% change. Track more INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) financial stats to get the full picture.
No, 0A43 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 122.00 employees. See our rating of the largest employees — is INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) EBITDA is ‪−116.89 M‬ USD, and current EBITDA margin is ‪−15.83 K‬%. See more stats in INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) financial statements.
Like other stocks, 0A43 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) stock shows the strong sell signal. See more of INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.